Anzeige
Mehr »
Login
Dienstag, 18.03.2025 Börsentäglich über 12.000 News von 691 internationalen Medien
Explosives Potenzial: Diese Aktie könnte durch diese News JETZT durch die Decke gehen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AF0E | ISIN: US24906P1093 | Ticker-Symbol: DY2
Tradegate
17.03.25
15:47 Uhr
14,285 Euro
-0,020
-0,14 %
1-Jahres-Chart
DENTSPLY SIRONA INC Chart 1 Jahr
5-Tage-Chart
DENTSPLY SIRONA INC 5-Tage-Chart
RealtimeGeldBriefZeit
14,25014,29017.03.
14,21514,34517.03.
GlobeNewswire (Europe)
135 Leser
Artikel bewerten:
(0)

DENTSPLY SIRONA Inc.: Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader

Finanznachrichten News

CHARLOTTE, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (XRAY) today announced that David Ferguson has been appointed Senior Vice President, Global Business Unit Leader, effective March 14, 2025. In this role he will lead the global business unit teams managing the dental product portfolio, serve as a member of the Executive Management Team and report directly to Chief Executive Officer, Simon Campion.

David Ferguson joins Dentsply Sirona with 25 years of experience in MedTech and healthcare with a proven track record of delivering results, competing in a global marketplace and leading global product strategy. Mr. Ferguson has served in leadership roles at well-known companies and brands, including GE Healthcare, Baxter and Philips.

Simon Campion, President and Chief Executive Officer of Dentsply Sirona, said, "We are delighted to welcome David as our new Global Business Unit Leader. With his experience in developing and executing strategic growth plans, as well as building and aligning high-performing teams, he brings invaluable expertise to our organization. His deep business acumen will be key to driving improved business performance and capitalizing on strategic opportunities that exist with our broad and differentiated portfolio. We are confident that David's leadership will further strengthen our position in the market."

David Ferguson said, "I'm excited to join Dentsply Sirona and contribute to shaping the next chapter alongside an incredible global team. With its broad-based portfolio, Dentsply Sirona is well positioned to capitalize on the evolving competitive landscape. I look forward to collaborating with the team to enhance execution, drive financial, operational, and strategic goals, and profitable growth."

About David Ferguson

David Ferguson is a seasoned executive with extensive leadership experience in the medical device and healthcare industries. He has a strong track record of driving revenue growth, strategic transformation, and operational excellence across multiple global businesses. Most recently, he was President of Gore Medical, a unit of W.L. Gore. Previously, as EVP at Philips and President & CEO of Philips Respironics, he managed a global team of 6,000 people. At Baxter Healthcare, he led the global infusion therapy, IV solutions and patient monitoring business. He also held leadership roles at GE Healthcare.

Mr. Ferguson is a Graduate of the Advanced Management Program of University of Chicago Booth School of Business and holds a PhD in Chemistry from Texas A&M University and Bachelor of Science in Biochemistry from David Lipscomb University. He has served on multiple boards, including AZBio, Philips PAC, and Baxter International Foundation, and is a co-inventor of two U.S. patents and author of ten peer-reviewed publications.

About Dentsply Sirona
Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide, high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona's headquarters is located in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information

Investors:
Andrea Daley
Vice President, Investor Relations
+1-704-591-8631
InvestorRelations@dentsplysirona.com

Press:
Marion Par-Weixlberger
Vice President, Public Relations & Corporate Communications
+43 676 848414588
marion.par-weixlberger@dentsplysirona.com


© 2025 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.